<?xml version="1.0" encoding="UTF-8"?>
<ref id="R40">
 <label>40</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Boevé</surname>
    <given-names>LMS</given-names>
   </string-name>, 
   <string-name>
    <surname>Hulshof</surname>
    <given-names>MCCM</given-names>
   </string-name>, 
   <string-name>
    <surname>Vis</surname>
    <given-names>AN</given-names>
   </string-name>, 
   <etal>et al</etal>
  </person-group>. 
  <article-title>Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in patients with primary bone metastatic prostate cancer in a prospective randomised clinical trial: data from the HORRAD trial</article-title>. 
  <source>Eur Urol</source>
  <year>2019</year>;
  <volume>75</volume>:
  <elocation-id>e129</elocation-id>:
  <fpage>410</fpage>–
  <lpage>8</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.eururo.2018.09.008</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30266309?>
  <pub-id pub-id-type="pmid">30591351</pub-id>
 </mixed-citation>
</ref>
